Babu Yarlagadda S
Chief Discovery Officer | Senior VP - Drug Discovery
1 company
Insider Signal Score
66
StrongTrades Analyzed
3
12M Win Rate
100.0%
Avg 3M Return
+7.6%
Avg 12M Return
+41.2%
Babu Yarlagadda S is a Chief Discovery Officer at BIOCRYST PHARMACEUTICALS INC. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $2.8M based on current market prices.
Holdings by Company
BCRXNov 14, 2022
Current Shares280.1K
Value$2.78M
Net Activity-86,615
Bought: 25.0KSold: 111.6K
Transaction History
Showing 5 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sale+OE | 31,515 | $13.88 | $437,428.20 | -9.5% | -25.1% | -61.2% | |
| Mar 7, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sell | 20,000 | $17.16 | $343,200.00 | -8.0% | -40.0% | -50.2% | |
| Dec 7, 2021 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sale+OE | 30,100 | $12.20 | $367,220.00 | -12.3% | +42.2% | -12.2% | |
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - Drug Discovery | Buy | 25,000 | $1.45 | $36,250.00 | +19.1% | - | - | |
| Aug 25, 2016 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - Drug Discovery | Sell | 30,000 | $4.06 | $121,800.00 | -21.2% | - | - |